Delta‐like protein 3 (DLL3) is an inhibitory NOTCH ligand specifically expressed on the surface of NE carcinoma, including SCLC, NEPC, and small cell bladder cancer, making it a potential therapeutic target.12, 149, 150. Here, DLL3 is linked to small cell lung carcinoma.